Warning letter
TEI Biosciences, Inc.: warning letter of Mar 6, 2019
FDA warning letter 573474 · Center for Devices and Radiological Health
Key facts
| Reference number | 573474 |
|---|---|
| Company | TEI Biosciences, Inc. |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Mar 6, 2019 |
| Posted date | Mar 19, 2019 |
| Issuing office | Center for Devices and Radiological Health |
| Product type | Devices |
| CFR sections cited | 820 |
| Inspection city | Boston |
| Inspection ZIP | 02127 |
| Inspection start date | Oct 9, 2018 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: